Ricardo Aguilar
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,100 of the $7,846 with a category attached, or 77.7%. Intuitive Surgical accounts for 79.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $6,336 and has fallen 91.2% since, to $560 in 2025.
Across 76 payments — averaging $103.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Johnson & Johnson$345
- TELA Bio, Inc.$247
- TAS Medical, Inc.$207
- AbbVie$180
- Medtronic$176
- plus $450 from 16 others
What the payments were for
- Food & beverage$1,74622%
- Education$6,10078%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $6,241 |
| Johnson & Johnson | 18 | $345 |
| TELA Bio, Inc. | 4 | $247 |
| TAS Medical, Inc. | 12 | $207 |
| AbbVie | 9 | $180 |
| Medtronic | 2 | $176 |
| Baxter Healthcare | 3 | $108 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Vertex | 2 | $41 |
| Merck | 2 | $32 |
| Boston Scientific | 2 | $32 |
| Olympus America Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Innovation Technologies Inc | 1 | $20 |
| Novo Nordisk | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Conmed Corporation | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,846 in reported general payments places this provider in the 80th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 51 | $3,412 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $184 |
| Tramadol Hcl | 27 | $41 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tulsa
- Craig JohnsonTulsa$573K
- Eugene DickensTulsa$456K
- William JenningsTulsa$412K
- Bryce MurrayTulsa$152K
- Steven FeherTulsa$50K
- Samuel PangburnTulsa$50K
- Jared LepleyTulsa$48K
- Ty KirkpatrickTulsa$28K
- John KingTulsa$24K
- Michael ThomasTulsa$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.